] lysate containing Sup35NMp and Sup35p. The cytosolic and 100S fractions did not cause aggregation of Sup35NMp, but all fractions of greater density-that is, 200S, 270S, and pellet-contained the conversion activity (Fig. 5) . Thus, the converting agent is not the Sup35p
PSIϩ monomer; rather, it appears to be Sup35p
PSIϩ aggregates. These results are compatible with the nucleation model for the Sup35p prion-like conversion. The absence of converting activity in the soluble fraction also suggests that the converting agent is not a cytosolic enzyme that modifies Sup35p. Purification of Sup35Sp
PSIϩ to apparent homogeneity (22) showed that the converting activity copurified with Sup35p aggregates (Fig. 5 ). This confirms the basic assumption of the prion model for [PSI ϩ ], that the converting agent is an altered form of Sup35p.
The above data allow us to explain the results of in vitro studies of the [ Our results demonstrate the general similarity of yeast and mammalian prions and provide a support for the "protein only" hypothesis for the inheritance of yeast [PSI ϩ ] phenotype. However, conversion of yeast Sup35p proceeds much more efficiently than that of mammalian PrP. The in vitro conversion of PrP C to PrP Sc requires more than 50-fold excess of PrP Sc over PrP C and incubation of mixed PrP C and PrP Sc for at least 2 days (3). These differences may be quantitative rather than qualitative and may be related to the in vivo properties of these prions. Yeast are rapidly dividing unicellular organisms, and the stable inheritance of [PSI ϩ ] requires that the time of its replication be less than that of a cell generation, that is, less than 2 hours during an exponential phase of growth. There is no such restriction for nondividing cells of brain tissues, in which the PrP Sc accumulation requires months (1). (13) was treated with ribonuclease A (500 g/ml) for 15 min at 20°C, a high salt concentration (1 M LiCl), and nonionic detergent (1% Triton X-100) for 20 min at 4°C and sedimented by centrifugation through a sucrose layer as described (16 During early development, cellular diversity is achieved by differences between cells in their patterns of gene expression. A good example of differential gene expression in lower eukaryotes occurs during the diploidization of homothallic strains of the budding yeast Saccharomyces cerevisiae (1) . Upon germination, haploid spores grow to a critical size and then produce buds. Anaphase takes place at the bud neck, and a complete set of chromosomes is delivered to both the mother cell and the daughter cell (bud). The mother cell can switch its mating type, but the daughter cell cannot. This difference is due to mother cell-specific transcription of the HO gene, which encodes an endonuclease that initiates gene conversion at the mating type locus (2) . Transcription of HO in mother cells is due to the unequal accumulation within REPORTS www.sciencemag.org ⅐ SCIENCE ⅐ VOL. 277 ⅐ 18 JULY 1997 daughter nuclei of a repressor of HO transcription called Ash1p (3). This accumulation depends on at least five SHE genes, one of which (SHE1, also known as MYO4) encodes a type V myosin (3) . Because mRNA localization is a common mechanism for generating asymmetric protein distribution in higher eukaryotes (4), we investigated the localization of ASH1 mRNA in the dividing yeast cell.
Using fluorescent in situ hybridization (FISH), we initially analyzed cells carrying the ASH1 gene on a multicopy plasmid (5, 6) . ASH1 mRNA-specific fluorescence was detected in 7% of the cells from an asynchronous culture. In binucleate cells that had undergone anaphase but not cell separation, ASH1 mRNA was concentrated at the distal tips of buds. Depending on the genetic background, 35 to 66% of the binucleate cells with a FISH signal showed localization of ASH1 mRNA. When ASH1 mRNA was not localized to the bud tip, it often appeared to form filamentous tracks extending from daughter cells into mother cells. In contrast to ASH1 mRNA, polyadenylated [poly(A) ϩ ] RNA was dispersed throughout both mother and daughter cells ( To determine if localization of ASH1 mRNA to the bud tip resulted in higher rates of Ash1p synthesis in daughter cells, we simultaneously monitored the accumulation of ASH1 mRNA and Ash1p produced by an epitope-tagged ASH1 gene integrated at the ASH1 locus (Fig. 1B) . Ash1p accumulated within the daughter nucleus near the ASH1 mRNA, which appeared to be "tracking" through the bud neck to the tip.
The she mutants that do not localize Ash1p asymmetrically (3) might do so by mislocalizing ASH1 mRNA. Analysis of the she mutants revealed that ASH1 mRNA was present in binucleate or unbudded uninucleate cells but that it was no longer asymmetrically distributed (Fig. 2) . In myo4, she2, she3, and she4 mutants, ASH1 mRNA was commonly distributed in a filamentous-like fashion or in patches at the cell periphery. In contrast, in she5/bni1 mutants, ASH1 mRNA was mainly concentrated in patches near the bud neck.
The dependence of ASH1 mRNA localization on the nonessential type V myosin Myo4 suggests that the actin cytoskeleton might participate in the asymmetric accumulation of ASH1 mRNA and protein. We therefore analyzed the distribution of ASH1 mRNA and Ash1p in strains carrying mutations that affect actin function. The act1-133 temperature-sensitive mutation affects the myosin-binding site on actin and prevents bud formation at the restrictive temperature (7) . In mutant cells growing at the permissive temperature, ASH1 mRNA was rarely localized to the bud (Fig. 3A) , and Ash1p accumulation in binucleate cells was rarely asymmetric (8) . Although the ASH1 mRNA was diffusely localized in this mutant, the daughter cell often contained higher amounts of mRNA than the mother cell.
We also investigated the distribution of ASH1 mRNA and Ash1p in mutants lacking the TPM1 gene that codes for the major SCIENCE ⅐ VOL. 277 ⅐ 18 JULY 1997 ⅐ www.sciencemag.org tropomyosin isotype in yeast or in mutants that are defective in the profilin gene (PFY1) (Fig. 3B) (9) . ASH1 mRNA was not localized in either mutant but rather had a distribution similar to that observed in the she1to she4 mutants. Ash1p accumulation was rarely asymmetric in binucleate cells (8) . All three mutants (act1, tpm1, and pfy1) affect the formation of actin cables that run from mother cells into their buds (7, 9) .
The defective ASH1 mRNA and protein localization in these mutants was not an indirect effect of the perturbation in bud formation. Mutants carrying a temperaturesensitive allele of myo2, which encodes a type V myosin that is essential for bud formation (10), showed asymmetric localization of ASH1 mRNA and protein at both permissive and restrictive temperatures (Fig. 3C) .
To determine if the ASH1 mRNA at the bud tip was transported through the bud neck and to test whether microtubules are involved in the transport, we analyzed the distribution of ASH1 mRNA in a tub2-401 mutant strain, which is defective in the formation of astral microtubules needed for anaphase to take place at the bud neck (11) . Nuclear division occurs entirely within mother cells when this mutant is shifted to the restrictive temperature (18°C). The ASH1 mRNA was still localized to the distal bud tip even when nuclear division had occurred within the mother cell (Fig. 4A) , indicating that the cells can transport ASH1 mRNA from the mother cell to the bud tip, despite disruption of microtubules.
The question of whether the ASH1 mRNA is transported from mother cell nuclei to bud tips was also addressed by experiments in which ASH1 mRNA was expressed at a stage when there was only a single nucleus. In these experiments, ASH1 mRNA was expressed from the promoter for the GAL1 and GAL10 genes, which is inducible by the addition of galactose to the medium (12) . The ASH1 mRNA localized to the bud at all stages of the cell cycle, from the beginning of bud formation during late G 1 to the end of anaphase when ASH1 mRNA is normally produced; however, no ASH1 mRNA was detectable when its expression was repressed by glucose (Fig. 4B) . This result demonstrates that (i) the mRNA localization mechanism is functional throughout most of the cell cycle; (ii) the mRNAs that are transported to the bud tip include those made within mother cell nuclei; and (iii) the factors at the bud tip that are responsible for attracting or anchoring ASH1 mRNA are there from the onset of bud formation.
In higher eukaryotic cells, cis-acting sequences that are necessary for mRNA lo- Transformants were grown to midlogarithmic phase at the permissive temperature (30°C), and a portion of the culture was shifted to the restrictive temperature (18°C) for 90 min. A second portion of the culture was maintained at 30°C for 90 min. Note at the nonpermissive temperature (18°C) the presence of two nuclei in mother cells, as shown by DAPI staining. (B) ASH1 mRNA localization when expressed from a galactose inducible promoter. Strain K6278 was transformed with plasmid C3348, a derivative of YCplac133 that encodes ASH1-myc9 under the control of the galactose-inducible promoter GAL1 (17 ) . Transformants were grown to midlogarithmic phase in synthetic liquid media (minus uracil) containing either 2% glucose (repressing conditions) or 3% galactose (inducing conditions).
REPORTS
www.sciencemag.org ⅐ SCIENCE ⅐ VOL. 277 ⅐ 18 JULY 1997 calization are often confined to the 3Ј-untranslated region (3Ј-UTR) of the mRNA (4, 13) . To address whether ASH1 mRNA contains a localization signal in its 3Ј-UTR, a hybrid mRNA was constructed and expressed in yeast. The Escherichia coli lacZ coding sequence was fused to 250 nucleotides of ASH1 3Ј-UTR, and the resultant hybrid mRNA expressed from the GAL1 promoter was detected by FISH. Localization of the hybrid mRNA to the bud in uninucleate small budded cells and to daughters in binucleate budded cells was dependent on the ASH1 3Ј-UTR (Fig. 5) and did not occur when the 3Ј-UTR from another mRNA (ADHII) was substituted (Fig. 5) . The localization to buds of the hybrid mRNA containing the ASH1 3Ј-UTR was dependent on SHE1, because she1 mutant cells no longer localize the hybrid mRNA (Fig. 5) . Thus, the 3Ј-UTR of the ASH1 mRNA appears to contain a cisacting sequence element that is sufficient to target a heterologous mRNA to the bud. However, the ASH1 mRNA may contain redundant cis-acting factors that are responsible for ASH1 mRNA localization, because replacement of the 3Ј-UTR of ASH1 with that of CDC6 only reduced ASH1 mRNA localization from 56 to 40% and Ash1p asymmetry from 92 to 82%.
The data presented here suggest that localization of ASH1 mRNA is responsible for the asymmetry in mating type switching through Ash1p. Microscopically, we have shown the juxtaposition of the mRNA in the cytoplasm and the protein in the nucleus (Fig. 1B) . Additionally, we have shown that mutations in eight different genes, which cause symmetrical Ash1p accumulation, also abolish localization of ASH1 mRNA. These observations strongly suggest that ASH1 mRNA localization is necessary for protein asymmetry. It is unlikely that all these mutations affect independently both mRNA localization and protein asymmetry, especially as some of the mutations (myo4, she2, and she3) are not very pleiotropic.
Cytoplasmic microtubules are thought to have a major role in mRNA localization both in Drosophila and Xenopus oocytes (4). However, actin has been shown to be the filament system that is important for the localization of ␤-actin mRNA in fibroblasts (14) . Microtubules are probably not involved in ASH1 mRNA localization, because disruption of astral microtubules by the tub2-401 mutation had little or no effect, even though it did prevent nuclei from migrating to the bud neck. Instead, we found that mutations that affect what is presumably an actin-dependent motor protein, Myo4p, as well as mutations in tropomyosin, profilin, and actin itself, all greatly reduce or even abolish ASH1 mRNA localization to the distal tip. Both profilin and cytoplasmic tropomyosin have been implicated in localizing oskar mRNA to the posterior pole of Drosophila oocytes (15) .
We have shown that a mechanism that is capable of moving ASH1 mRNA to the bud tip exists long before ASH1 mRNA is actually made in the cell. Possibly, the true cargo for Myo4p is not ASH1 mRNA itself but some bud tip-specific protein to which ASH1 mRNA stably binds. Such hypothetical proteins have also been postulated to be the determinants of budding axis in diploid cells (16) . ASH1 mRNA, therefore, might not be actively transported at all but merely bound to a receptor, which had previously been delivered to the daughter cell cortex by Myo4p. Irrespective of the actual mechanism by which ASH1 mRNA is localized, it would seem likely that proteins localized to the distal bud tip act either as addresses or anchors for ASH1 mRNA. Curiously, none of the proteins currently implicated in ASH1 mRNA localization are known to be localized at the bud tip at the end of anaphase. This leads us to suspect that as yet unknown components of the localization mechanism await discovery. Likewise, it is probable that other yeast mRNA will be found to be localized to the bud tip or neck.
In multicellular organisms, most localized mRNAs code for proteins involved with differential gene expression. Our data show that asymmetric intracellular mRNA localization is not confined to cells from the animal kingdom or to those from multicellular organisms (4, 13) . In this light, mRNA localization might be seen as a precursor to, or a substitute for, differential gene expression to generate spatial complexity of proteins. (5) or pXMRS25 (26). Plasmid pHZ18-poly(A) contains the lacZ reporter gene with the ADHII 3Ј-UTR, whereas pXMRS25 contains the 3Ј-UTR of ASH1 in place of ADHII sequences. In situ hybridizations to lacZ were performed as described previously with the described modifications (5, 23) .
SCIENCE ⅐ VOL. 277 ⅐ 18 JULY 1997 ⅐ www.sciencemag.org competitor DNA were reduced from 100 ng and 200 g to 10 ng and 20 g, respectively. The composition of buffer B was 1.2 M sorbitol and 10 mM KHPO 4 at pH 7.5. After the second posthybridization wash in 40% formamide and 2ϫ standard saline citrate (SSC), a 15-min wash at room temperature in 2ϫ SSC and 0.1% Triton X-100 was done. The oligonucleotide probes were as follows: 5Ј-GCT T*GCCT TGT TGAAT T*CTG-GTGAAT T*GCCTGGTGT T*AATGAGGAAAT T*GG-3Ј, 5Ј-GATGCCT T*AGTGATGGT*AGGCT T TGT TGT*-GGGCGCTCCGGT*CTCT TAGAT*A-3Ј, 5Ј-GGA-ACT T*GGACGACCTAGT*CGAT TCCAAT T*CCT T-GCCGT*AAT TGAAACT*AT-3Ј, 5Ј-AT*GGT TCTA-T T*GGT TGGTGGACT*CATCGGCGGTGT*GACG-GGAGGAGTAAT*A-3Ј, 5Ј-AAGCT* T TGAAACTG-T T*CGTCT T T TTGT*GACTGGCAT T T*GGCATGG-GAAAT*G-3Ј, and 5Ј-GT*CGAGAGCAAATCTAT*-GATAAT TGGG*GACCT TGGGCT* TGGAGTGTAT*-GC-3Ј. The probes were directly labeled with a Cy3 fluorochrome at amino-modified thymidine residues indicated by the asterisks (19) . To detect poly(A) ϩ RNA, FISH was performed with T43 labeled with fluorescein isothiocyanate (20) . In formamidecontaining solutions, the concentration was reduced to 10% for poly(A) ϩ RNA detection. Images were taken with an Olympus IX70 inverted epifluorescence microscope and Oncor (Gaithersburg, MD) imaging software, version 2.0.5. 24. Strain K5552, which encodes an epitope-tagged version of Ash1p (Ash1p-myc9), was grown to midlogarithmic phase, fixed, and processed for simultaneous FISH and immunofluorescence. After FISH, immunofluorescence was performed as described previously (21) with the following alterations. Antibody to myc was diluted 1: 5 into a solution of 1ϫ phosphate-buffered saline, 0.1% bovine serum albumin, 20 mM vanadyl ribonucleoside complex, and ribonuclease inhibitor (40 U/l). The secondary antibody, goat antibody to mouse immunoglobulin G, conjugated to dichlorotrianzinyl amino fluorescein (Jackson Laboratories), was diluted 1: 50 into the same solution. 25. Plasmid C3431 is a derivative of YEplac195 (17 ) carrying a Sal I-Sac I ASH1 fragment. 26. Plasmid pHZ18-poly(A) containing the ADHII 3Ј-UTR has been described (5). Plasmid pXMRS25 was constructed from pHZ18 (22) by insertion of an ASH1 fragment generated by the polymerase chain reaction (PCR). The PCR product contained the last five amino acid codons of ASH1 and extended 250 nucleotides beyond the stop codon. The ASH1 fragment was subcloned into the Sac I site of pHZ18 by the inclusion of a Sac I restriction site in the PCR primers. The primers for PCR were 5Ј-GGGC-CCGAGCTCGAGACAGTAGAGAAT TGATACATG-3Ј and 5Ј-GGGCCCGAGCTCATCAGGATGAC-CAATCTAT TGCGC-3Ј. To verify that no mutations were introduced by PCR, the ASH1 region of plasmid pXMRS25 was confirmed by DNA sequencing. 27. We thank M. Rosbash As part of an ongoing multicenter study of the genetics of idiopathic PD, we have ascertained 94 Caucasian families (a total of 213 affected relatives sampled: 108 affected sibpairs and 31 affected relative pairs) with at least two individuals in each family meeting clinical criteria for idiopathic PD (3). We have identified approximately 200 multiplex idiopathic PD families to ascertain for a genomic screen. The 94 families discussed here were those completely ascertained, with DNA sampled, at the time of the analysis. Linkage analysis of chromosome 4q21-q23 markers in these idiopathic PD families did not reveal evidence for linkage of an autosomal dominant, highly penetrant gene, as was described by Polymeropoulos et al. (1, 4) . We determined two-point log odds (lod) scores, with the use of the model of Polymeropoulos et al. as well as a low penetrance "affecteds-only" autosomal dominant model. These lod scores were strongly negative for markers D4S2361, D4S2409, D4S2380, D4S1647, and D4S2623. Multipoint analysis of the genetic map D4S2361-17cM-D4S1647-10.5cM-D4S2623 supported these findings for both models, excluding the entire candidate region. We found no evidence for heterogeneity of either the two-point (P Ͼ 0.20) or multipoint (ln likelihood ϭ 1) lod scores (5) . Because the power of the parametric lod score method suffers when the genetic model is misspecified, we also used nonparametric analyses of affected relative pairs (6) . As with the parametric lod score analysis, we found no significant evidence for linkage using either two-point or multipoint analysis; in this data set, the multipoint location scores (MLS) exclude the entire 27.5 cM region for recurrence risks to siblings as low as 2.5 ( Fig. 1) . Because the pedigree analyzed by Polymeropoulos et al. contained many younger onset cases (mean age at onset of the disease was 46), we repeated our analysis in the 22 families with at least one affected individual with an onset earlier than age 45; the analysis in the subset supported the results from the full sample (7) .
The absence of linkage to chromosome 4q21-q23 in our dataset indicates that there is genetic heterogeneity in PD. It is possible that the region identified by Polymeropoulos et al. harbors a disease locus responsible only for a rare autosomal dominant form of PD. Such a situation would be analogous to the genetics of Alzheimer's disease (AD), where mutations (in the amyloid precursor protein and the presenilin 1 and presenilin 2 genes) that cause autosomal dominant AD are responsible for less than 2% of all cases (8) . Therefore, although the report by Polymeropoulos et al. is a first step in unraveling the genetic etiology of PD, other independent genetic effects likely remain to be discovered. 
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